...
search icon
ppbt-img

Purple Biotech Share Price

PPBT
NAQ
$0.576
-$0.01
(-1.71%)
1D
Industry: Biotechnology Sector: Health Care

Purple Biotech Analyst Forecast

Purple Biotech Share Price Chart

Purple Biotech Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$5.28M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
102.78K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
-0.74
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.53 L
$3.48 H
$0.576

About Purple Biotech, Common Stock

Purple Biotech Ltd., a clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug resistance for cancer patients in the United States. Its oncology pipeline includes CM24, a humanized monoclonal antibody that blocks the interactions of carcinoembryonic antigen related cell adhesion molecule 1 as a combination therapy with anti-PD-1 checkpoint inhibitors, which is in Phase 2 clinical trial for the treatment of pancreatic ductal adenocarcinoma; NT219, a small molecule that targets and inhibits insulin receptor substrate 1 and 2, and signal transducer and activator of transcription, which is in Phase 1/2 clinical trials for the treatment recurrent and/or metastatic squamous cell carcinoma of the head and neck cancer or colorectal adenocarcinoma; and IM1240, a multi-valent antibody designed to activate anti-tumoral immune response against 5T4-positive tumors, which is in preclinical stage. The company has collaboration agreement with Bristol Myers Squibb Company to evaluate the combination of CM24 with the PD-1 inhibitor nivolumab in addition to chemotherapy. The company was formerly known as Kitov Pharma Ltd and changed its name to Purple Biotech Ltd. in December 2020. The company was incorporated in 1968 and is headquartered in Rehovot, Israel. more

Industry: BiotechnologySector: Health Care

Purple Biotech Stock Returns

Time FramePPBTSectorS&P500
1-Week Return-3.19%0.72%-1.31%
1-Month Return-4.79%1.27%0.78%
3-Month Return-28.09%3.13%3.46%
6-Month Return-74.63%15.81%6.19%
1-Year Return-82.11%8.89%11.68%
3-Year Return-98.67%20.79%71.21%
5-Year Return-99.53%35.89%74.81%
10-Year Return-99.89%138.44%256.59%

Purple Biotech Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue1.00M(320.00K)(910.00K)195.80K-[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-32,"profit":false},{"date":"2022-12-31","value":-91,"profit":false},{"date":"2023-12-31","value":19.58,"profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Cost of Revenue58.0055.00120.00196.00K186.00K[{"date":"2020-12-31","value":0.03,"profit":true},{"date":"2021-12-31","value":0.03,"profit":true},{"date":"2022-12-31","value":0.06,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":94.9,"profit":true}]
Gross Profit999.94K(55.00)(120.00)(196.00)(186.00K)[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-0.01,"profit":false},{"date":"2022-12-31","value":-0.01,"profit":false},{"date":"2023-12-31","value":-0.02,"profit":false},{"date":"2024-12-31","value":-18.6,"profit":false}]
Gross Margin99.99%0.02%0.01%(0.10%)-[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":0.02,"profit":true},{"date":"2022-12-31","value":0.01,"profit":true},{"date":"2023-12-31","value":-0.1,"profit":false},{"date":"2024-12-31","value":"-","profit":true}]
Operating Expenses13.24M17.93M22.60M(22.47M)11.01M[{"date":"2020-12-31","value":58.57,"profit":true},{"date":"2021-12-31","value":79.34,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-99.4,"profit":false},{"date":"2024-12-31","value":48.69,"profit":true}]
Operating Income(13.24M)(17.93M)(22.60M)(22.27M)(11.01M)[{"date":"2020-12-31","value":-1323900000,"profit":false},{"date":"2021-12-31","value":-1793400000,"profit":false},{"date":"2022-12-31","value":-2260300000,"profit":false},{"date":"2023-12-31","value":-2227100000,"profit":false},{"date":"2024-12-31","value":-1100500000,"profit":false}]
Total Non-Operating Income/Expense(15.27M)216.00K1.69M587.00K3.51M[{"date":"2020-12-31","value":-434.52,"profit":false},{"date":"2021-12-31","value":6.15,"profit":true},{"date":"2022-12-31","value":47.98,"profit":true},{"date":"2023-12-31","value":16.7,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Pre-Tax Income(28.70M)(17.83M)(21.76M)(19.98M)(7.28M)[{"date":"2020-12-31","value":-2870100000,"profit":false},{"date":"2021-12-31","value":-1782600000,"profit":false},{"date":"2022-12-31","value":-2176000000,"profit":false},{"date":"2023-12-31","value":-1997700000,"profit":false},{"date":"2024-12-31","value":-727900000,"profit":false}]
Income Taxes(15.67M)637.00K877.00K(97.00K)-[{"date":"2020-12-31","value":-1786.66,"profit":false},{"date":"2021-12-31","value":72.63,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-11.06,"profit":false},{"date":"2024-12-31","value":"-","profit":true}]
Income After Taxes(13.03M)(18.46M)(22.64M)(19.88M)-[{"date":"2020-12-31","value":-1303200000,"profit":false},{"date":"2021-12-31","value":-1846300000,"profit":false},{"date":"2022-12-31","value":-2263700000,"profit":false},{"date":"2023-12-31","value":-1988000000,"profit":false},{"date":"2024-12-31","value":"-","profit":true}]
Income From Continuous Operations(28.07M)(17.83M)(21.76M)(19.98M)(7.28M)[{"date":"2020-12-31","value":-2807400000,"profit":false},{"date":"2021-12-31","value":-1782600000,"profit":false},{"date":"2022-12-31","value":-2176000000,"profit":false},{"date":"2023-12-31","value":-1997700000,"profit":false},{"date":"2024-12-31","value":-727900000,"profit":false}]
Income From Discontinued Operations(642.00K)(642.00K)---[{"date":"2020-12-31","value":-64200000,"profit":false},{"date":"2021-12-31","value":-64200000,"profit":false},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(28.00M)(18.38M)(21.67M)(19.88K)(7.24M)[{"date":"2020-12-31","value":-2799900000,"profit":false},{"date":"2021-12-31","value":-1838400000,"profit":false},{"date":"2022-12-31","value":-2166800000,"profit":false},{"date":"2023-12-31","value":-1988000,"profit":false},{"date":"2024-12-31","value":-724000000,"profit":false}]
EPS (Diluted)(0.07)(0.42)(1.21)(0.93)(1.87)[{"date":"2020-12-31","value":-7,"profit":false},{"date":"2021-12-31","value":-42,"profit":false},{"date":"2022-12-31","value":-120.99,"profit":false},{"date":"2023-12-31","value":-92.61,"profit":false},{"date":"2024-12-31","value":-186.69,"profit":false}]

Purple Biotech Ratios

Purple Biotech Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

PPBT
Cash Ratio 1.73
Current Ratio 1.78

Purple Biotech Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

PPBT
ROA (LTM) -10.27%
ROE (LTM) -8.56%

Purple Biotech Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

PPBT
Debt Ratio Lower is generally better. Negative is bad. 0.16
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.84

Purple Biotech Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

PPBT
Trailing PE NM
Forward PE NM
P/S (TTM) 58.08
P/B 0.16
Price/FCF NM
EV/R 33.08
EV/Ebitda NM

FAQs

What is Purple Biotech share price today?

Purple Biotech (PPBT) share price today is $0.576

Can Indians buy Purple Biotech shares?

Yes, Indians can buy shares of Purple Biotech (PPBT) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in PPBT stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Purple Biotech be purchased?

Yes, you can purchase fractional shares of Purple Biotech (PPBT) via the Vested app. You can start investing in Purple Biotech (PPBT) with a minimum investment of $1.

How to invest in Purple Biotech shares from India?

You can invest in shares of Purple Biotech (PPBT) via Vested in three simple steps:

  • Click on Sign Up or Invest in PPBT stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Purple Biotech shares
What is Purple Biotech 52-week high and low stock price?

The 52-week high price of Purple Biotech (PPBT) is $3.48. The 52-week low price of Purple Biotech (PPBT) is $0.53.

What is Purple Biotech price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Purple Biotech (PPBT) is

What is Purple Biotech price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Purple Biotech (PPBT) is 0.16

What is Purple Biotech dividend yield?

The dividend yield of Purple Biotech (PPBT) is 0.00%

What is the Market Cap of Purple Biotech?

The market capitalization of Purple Biotech (PPBT) is $5.28M

What is Purple Biotech's stock symbol?

The stock symbol (or ticker) of Purple Biotech is PPBT

How Can Investors Use Purple Biotech Share Price Data for Long-Term Investment Decisions?

Consider the share price of Purple Biotech as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Purple Biotech has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Purple Biotech shares for Indian investors?

When investing in Purple Biotech shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Purple Biotech stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Purple Biotech share price with other stocks in the same sector?

Rather than merely checking the share price of Purple Biotech and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Purple Biotech stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top